Please Wait
Applying Filters...
menu
    • menu
    Athena Pharmaceutiques is a Partner of Choice for Drug Delivery & Life Cycle Management.

    Virtual Booth

    Contact Supplier

    Kikkoman Biochemifa Company advances global health and safety through precision-driven innovation in biotech and food testing.

    Virtual Booth

    Contact Supplier

    Rusan Pharma: Over 30 years of specializing in the treatment of Addiction and Pain Management.

    Virtual Booth

    Contact Supplier

    TransoPharm USA works in the Sourcing and Management of Active Pharmaceutical Ingredients.

    Virtual Booth

    Contact Supplier

    Moehs Group, a reference company in the production of pharmaceutical active ingredients.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-10-20

    Virtual Booth

    An Enquiry

    Menu

    Ropidoxuridine

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Shuttle Pharma Secures Definitive LOI For Molecule.Ai
    Shuttle Pharma Secures Definitive LOI For Molecule.Ai

    21 Oct 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-10-21/shuttle-pharma-turns-radiation-into-a-smart-weapon-with-definitive-loi-for-moleculeai-nasdaqshph

    PHARMIWEB
    21 Oct 2025
    Share Share
    Shuttle Hits Milestone For Glioblastoma Trial Enrollment Target
    Shuttle Hits Milestone For Glioblastoma Trial Enrollment Target

    21 Jan 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/01/21/3012743/0/en/Shuttle-Pharma-Reaches-Milestone-in-Patient-Enrollment-for-Phase-2-Clinical-Trial-of-Ropidoxuridine-for-Treatment-of-Patients-with-Glioblastoma.html

    GLOBENEWSWIRE
    21 Jan 2025
    Share Share
    Shuttle Pharma Doses First Patients in Glioblastoma Trial
    Shuttle Pharma Doses First Patients in Glioblastoma Trial

    29 Oct 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/10/29/2970880/0/en/Shuttle-Pharma-Doses-First-Patients-in-Phase-2-Clinical-Trial-of-Ropidoxuridine-for-Treatment-of-Patients-with-Glioblastoma.html

    GLOBENEWSWIRE
    29 Oct 2024
    Share Share
    Shuttle Pharma Expands Trial For Glioblastoma Treatment
    Shuttle Pharma Expands Trial For Glioblastoma Treatment

    16 Sep 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/09/16/2946677/0/en/Shuttle-Pharma-Expands-Clinical-Trial-Site-Enrollment-for-Phase-2-of-Ropidoxuridine-for-Treatment-of-Patients-with-Glioblastoma.html

    GLOBENEWSWIRE
    16 Sep 2024
    Share Share
    Shuttle Pharma Provides Second Quarter 2024 Corporate Update
    Shuttle Pharma Provides Second Quarter 2024 Corporate Update

    04 Sep 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/09/04/2940918/0/en/Shuttle-Pharma-Provides-Second-Quarter-2024-Corporate-Update.html

    GLOBENEWSWIRE
    04 Sep 2024
    Share Share
    Plus Therapeutics Reports Q2 2024 Financial Results And Business Highlights
    Plus Therapeutics Reports Q2 2024 Financial Results And Business Highlights

    14 Aug 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/08/14/2930509/0/en/Plus-Therapeutics-Reports-Second-Quarter-2024-Financial-Results-and-Recent-Business-Highlights.html

    GLOBENEWSWIRE
    14 Aug 2024
    Share Share